300705 Stock Overview
Researches, develops, produces, and sells pharmaceutical products in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Hunan Jiudian Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥22.84 |
| 52 Week High | CN¥28.75 |
| 52 Week Low | CN¥17.77 |
| Beta | 0.54 |
| 1 Month Change | -1.51% |
| 3 Month Change | 21.49% |
| 1 Year Change | -7.42% |
| 3 Year Change | 36.73% |
| 5 Year Change | 278.41% |
| Change since IPO | 499.68% |
Recent News & Updates
We Think Hunan Jiudian Pharmaceutical (SZSE:300705) Can Stay On Top Of Its Debt
Nov 29
Do Hunan Jiudian Pharmaceutical's (SZSE:300705) Earnings Warrant Your Attention?
Oct 22Recent updates
We Think Hunan Jiudian Pharmaceutical (SZSE:300705) Can Stay On Top Of Its Debt
Nov 29Do Hunan Jiudian Pharmaceutical's (SZSE:300705) Earnings Warrant Your Attention?
Oct 22With Hunan Jiudian Pharmaceutical Co., Ltd. (SZSE:300705) It Looks Like You'll Get What You Pay For
Aug 12Here's Why Hunan Jiudian Pharmaceutical (SZSE:300705) Can Manage Its Debt Responsibly
Jun 23Hunan Jiudian Pharmaceutical (SZSE:300705) Is Increasing Its Dividend To CN¥0.321
May 21Here's Why We Think Hunan Jiudian Pharmaceutical (SZSE:300705) Might Deserve Your Attention Today
Apr 12Earnings Not Telling The Story For Hunan Jiudian Pharmaceutical Co., Ltd. (SZSE:300705) After Shares Rise 27%
Mar 04Shareholder Returns
| 300705 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -8.6% | -1.9% | -1.2% |
| 1Y | -7.4% | -1.8% | 11.8% |
Return vs Industry: 300705 underperformed the CN Pharmaceuticals industry which returned -1.8% over the past year.
Return vs Market: 300705 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 300705 volatility | |
|---|---|
| 300705 Average Weekly Movement | 8.2% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300705 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300705's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 1,893 | Yang Yang | www.hnjiudian.com |
Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. Its leading products are loxoprofen sodium gel plaster and hydrochloric acid. The company offers its products in the anti-inflammatory and analgesic, anti-infective, anti-allergic, digestive system, cardiovascular and cerebrovascular, gynecological drugs, supplements, and other fields.
Hunan Jiudian Pharmaceutical Co., Ltd. Fundamentals Summary
| 300705 fundamental statistics | |
|---|---|
| Market cap | CN¥11.81b |
| Earnings (TTM) | CN¥508.01m |
| Revenue (TTM) | CN¥2.95b |
22.2x
P/E Ratio3.8x
P/S RatioIs 300705 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300705 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.95b |
| Cost of Revenue | CN¥768.25m |
| Gross Profit | CN¥2.18b |
| Other Expenses | CN¥1.67b |
| Earnings | CN¥508.01m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.03 |
| Gross Margin | 73.92% |
| Net Profit Margin | 17.25% |
| Debt/Equity Ratio | 15.4% |
How did 300705 perform over the long term?
See historical performance and comparisonDividends
1.0%
Current Dividend Yield22%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 10:45 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hunan Jiudian Pharmaceutical Co., Ltd. is covered by 11 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hao Wu | Chasing Securities |
| Yizheng Yang | China International Capital Corporation Limited |
| Kai Wang | Citic Securities Co., Ltd. |